Do cobalt chrome stent and paclitaxel-eluting stent have equivalent clinical result in noncomplex lesion? Two-year follow-up

被引：0
作者：
Gwon, Hyeon-Cheol [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2008年 / 51卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：B37 / B37
页数：1
相关论文
共 50 条
  • [11] The "Final" 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting Stent
    Kirtane, Ajay J.
    Leon, Martin B.
    Ball, Michael W.
    Bajwa, Harpaul S.
    Sketch, Michael H., Jr.
    Coleman, Patrick S.
    Stoler, Robert C.
    Papadakos, Stylianos
    Cutlip, Donald E.
    Mauri, Laura
    Kandzari, David E.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (04) : 325 - 333
  • [12] The "Final" Five-Year Follow-up front the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent with a Paclitaxel-Eluting Stent
    Leon, Martin B.
    Kandzari, David E.
    Mauri, Laura
    Ball, Michael W.
    Bajwa, Harpaul S.
    Sketch, Michael H.
    Coleman, Patrick S.
    Stoler, Robert C.
    Papadakos, Stylianos
    Cutlip, Donald E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B8 - B8
  • [13] Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I)
    Grube, E
    Silber, S
    Hauptmann, KE
    Buellesfeld, L
    Mueller, R
    Lim, V
    Gerckens, U
    Russell, ME
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (01) : 79 - 82
  • [14] TAXUS I paclitaxel-eluting stent trial: 3-year clinical follow-up.
    Grube, E
    Silber, S
    Hauptmann, KE
    Russell, ME
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A) : 131E - 131E
  • [15] The Paclitaxel-Eluting Coroflex™ Please Stent Pilot Study (PECOPS I)The one-year clinical follow-up
    Martin Unverdorben
    Ralf Degenhardt
    Marcus Wiemer
    Dieter Horstkotte
    Henrik Schneider
    Christoph Nienaber
    Wolfgang Bocksch
    Michael Gross
    Michael Boxberger
    Christian Vallbracht
    Clinical Research in Cardiology, 2007, 96 : 803 - 811
  • [16] Two-year clinical follow-up of the unrestricted use of the Paclitaxel-Eluting sent compared to the Sirolimus-Eluting Stent as part of the taxus-stent evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry
    Daemen, J
    Ong, ATL
    Valgimigli, M
    Rodriguez-Granillo, GA
    García-García, HM
    Tsuchida, K
    Vaina, S
    Tanimoto, S
    van Mieghem, CAG
    van Domburg, RT
    Serruys, PW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 22B - 22B
  • [17] Two-Year Clinical Outcomes of Paclitaxel-Eluting Stent for Diffuse Long Lesion in Asian Population; 38 mm Single Long Stent versus Two or More Overlapping Stents
    Rha, Seung-Woon
    Poddar, Kanhaiya L.
    Kumari, Meera
    Choi, Byoung Geol
    Kim, Yun Kyung
    Na, Jin Oh
    Choi, Cheol Ung
    Lim, Hong Euy
    Kim, Jin Won
    Kim, Eung Ju
    Park, Chang Gyu
    Seo, Hong Seog
    Oh, Doug Joo
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (8A) : 83A - 84A
  • [18] Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme
    Lee, Michael S.
    Yang, Tae
    Lasala, John M.
    Cox, David A.
    Bowman, Thomas S.
    Starzyk, Ruth M.
    Dawkins, Keith D.
    EUROINTERVENTION, 2011, 7 (03) : 314 - 322
  • [19] ASPECT study: 2-year follow-up of a polymer-free paclitaxel-eluting coronary stent
    Park, SJ
    Shim, WH
    Ho, DS
    Park, SW
    Raizner, AE
    Kaluza, GL
    Voorhees, WD
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A) : 59L - 60L
  • [20] One year follow-up of TAXUS-1: A randomized study with the paclitaxel-eluting NIR conformer stent
    Silber, S
    Hauptmann, KE
    Grube, E
    CIRCULATION, 2002, 106 (19) : 394 - 394
12345